SCM
CYTK icon

Shelton Capital Management’s Cytokinetics CYTK Stock Holding History

Shelton Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$267K Hold
4,049
– – 0.01% 553
2025
Q4 		$257K Buy
+4,049
New +$252K 0.01% 554
2024
Q4 		– Sell
-3,995
Closed -$211K – 743
2024
Q3 		$211K Hold
3,995
– – 0.01% 695
2024
Q2 		$216K Sell
3,995
-198
-5% -$12K 0.01% 656
2024
Q1 		$294K Sell
4,193
-458
-10% -$35.4K 0.01% 541
2023
Q4 		$388K Buy
+4,651
New +$168K 0.01% 396
2023
Q1 		– Sell
-5,392
Closed -$247K – 741
2022
Q4 		$247K Hold
5,392
– – 0.03% 531
2022
Q3 		$261K Hold
5,392
– – 0.01% 504
2022
Q2 		$212K Buy
+5,392
New +$217K 0.01% 647

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return